HCPCS 'E' Modifiers (15)

Modifier Description
E1 Upper left, eyelid
E2 Lower left, eyelid
E3 Upper right, eyelid
E4 Lower right, eyelid
EA Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy
EB Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy
EC Erythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy
ED Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
EE Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
EJ Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab
EM Emergency reserve supply (for esrd benefit only)
EP Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program
ET Emergency services
EX Expatriate beneficiary
EY No physician or other licensed health care provider order for this item or service